Insider · CIK 0001910132
Adrian W Quartel
Files at ZVRA (ZEVRA THERAPEUTICS, INC.), SPRB (SPRUCE BIOSCIENCES, INC.). First filing Feb 2, 2026, latest Feb 2, 2026.
In brief
Adrian W Quartel files SEC Form 4 as officer at ZVRA (ZEVRA THERAPEUTICS, INC.), and also at SPRB (SPRUCE BIOSCIENCES, INC.). Since Feb 2, 2026, Adrian W Quartel has reported 0 open-market buys worth $0 and 1 open-market sell worth $40k, the latest filed on Feb 2, 2026.
A track record needs three past buys with six months of prices behind them; Adrian W Quartel has 0, so none is measured yet.
The newest scored trade: sold $40k of ZVRA on Jan 30, 2026, filed Feb 2, 2026, scored 11 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $40k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZVRA: ZEVRA THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 11Weak | ZEVRA THERAPEUTICS, INC. | $40k 4,533 shares | -32% | +37% from low-30% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS INC | 4,533 0.01% of outstanding | $40k | Jan 30, 2026 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | SPRB SPRUCE BIOSCIENCES, INC. | AGrant or award Restricted Stock Unitsderivative | +13,000 | $0.00 | $0 | 13,000 | Jul 29, 2026 |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +11,333 | - | - | 14,256 | Feb 2, 2026 |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -4,533 | $8.83 | $40k | 9,723 | Feb 2, 2026 |
| Jan 29, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | AGrant or award Restricted Stock Unitderivative10b5-1 | +37,500 | $0.00 | $0 | 37,500 | Feb 2, 2026 |
| Jan 29, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative10b5-1 | +75,000 | $0.00 | $0 | 75,000 | Feb 2, 2026 |
| Jan 30, 2026 | ZVRA ZEVRA THERAPEUTICS, INC. | MOption exercise Restricted Stock Unitderivative10b5-1 | -11,333 | $0.00 | $0 | 22,667 | Feb 2, 2026 |
Questions about Adrian W Quartel
Answered from the filings on this page, as of the latest one.
Is Adrian W Quartel buying or selling?
In the last 12 months Adrian W Quartel reported 0 open-market buys worth $0 and 1 open-market sell worth $40k on SEC Form 4; the latest was sold $40k of ZVRA on Jan 30, 2026. Grants, option exercises and tax withholding are not counted.
How did Adrian W Quartel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adrian W Quartel has 0.
Where does Adrian W Quartel file Form 4?
Adrian W Quartel has filed Form 4 at ZVRA (ZEVRA THERAPEUTICS, INC.) as Chief Medical Officer; SPRB (SPRUCE BIOSCIENCES, INC.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.